Chengwei Peng

Also affiliated with Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Computer ScienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab”.

Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab

Cancer Immunology Research(2016)10.1158/2326-6066.cir-15-0281

N/A

0.464DataRank · unranked

21 citations

Richard Joseph, Chengwei Peng, Fei Ye, Shilin Zhao, Igor Puzanov +3 more

Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.24.671070

N/A

0DataRank · unranked

0 citations

Maayan Pour, Jaylen M Powell, Yuan Hao, Dimitris Nasias, Yi Jer Tan +27 more